- Report
- November 2023
- 189 Pages
Global
From €4671EUR$4,950USD£4,034GBP
- Report
- October 2023
- 167 Pages
Global
From €2359EUR$2,500USD£2,037GBP
- Report
- April 2020
- 269 Pages
Global
From €4010EUR$4,250USD£3,463GBP
- Report
- January 2022
- 200 Pages
Global
From €5661EUR$6,000USD£4,889GBP
€7077EUR$7,500USD£6,112GBP
- Report
- January 2022
- 60 Pages
Global
From €2982EUR$3,160USD£2,575GBP
€3727EUR$3,950USD£3,219GBP
- Clinical Trials
- February 2020
- 106 Pages
Global
From €1132EUR$1,200USD£978GBP
€1415EUR$1,500USD£1,222GBP
- Report
- August 2022
- 120 Pages
Global
From €4246EUR$4,500USD£3,667GBP
- Drug Pipelines
- October 2020
- 42 Pages
Global
From €1887EUR$2,000USD£1,630GBP
- Report
- October 2023
- 199 Pages
Global
From €3354EUR$3,554USD£2,896GBP
€3726EUR$3,949USD£3,218GBP
- Report
- October 2023
- 199 Pages
Global
From €3354EUR$3,554USD£2,896GBP
€3726EUR$3,949USD£3,218GBP
- Report
- June 2023
- 90 Pages
Global
From €3500EUR$3,973USD£3,129GBP
- Report
- November 2021
- 70 Pages
Global
From €1881EUR$1,994USD£1,625GBP
The Premature Ejaculation Drug market is a subset of the Sexual and Reproductive Health Drugs market. It is composed of drugs used to treat premature ejaculation, a condition in which a man ejaculates too quickly during sexual intercourse. These drugs are typically taken orally and work by increasing the time it takes for a man to ejaculate. Common side effects of these drugs include dizziness, headache, and nausea.
The Premature Ejaculation Drug market is growing due to increased awareness of the condition and the availability of treatments. This has led to an increase in demand for these drugs, as well as an increase in research and development of new drugs.
Some companies in the Premature Ejaculation Drug market include Pfizer, Eli Lilly, and Johnson & Johnson. These companies are involved in the research, development, and marketing of drugs to treat premature ejaculation. Show Less Read more
